Diagnostic Imaging International Corp. (OTCBB: DIIG) Stock Alert – CTS Bolster DIIG’s Growth Outlook; Co. Eyes Expansion

Las Vegas-based Diagnostic Imaging International Corp. (OTCBB: DIIG) provides remote radiology (teleradiology) technology to hospitals and practices through its subsidiary Canadian Teleradiology Services (CTS), and is looking ahead to a bright future amid sizable market opportunity.

The Las Vegas-based company acquired CTS in March 2009, and has been providing remote teleradiology services to hospitals, clinics and physician practices in North America for three years. These services are provided 24-hours-a-day, seven-days-a-week. Recently, CTS extended its largest service contract for five years, covering three public hospitals which it supplies with remote reading and reporting. The contract covers imaging modalities such as MRI, CT, X-Ray and Ultrasound.

Following the acquisition, CTS reported new agreements which expanded its client base and revenues. It announced contracts to supply teleradiology services to 10 additional hospitals in Ontario. Further, the company inked four new deals to supply day-time service to hospital already receiving nighttime service from CTS.

Having entered the North American imaging through its CTS acquisition, DIIG is reportedly planning to build a network of imaging clinics in Canada, where demand is forecast to grow 6% annually over the next decade. It also anticipates providing teleradiology services on a worldwide basis. According to reports, the company is actively pursuing acquisitions of existing, profitable private clinics in major metropolitan areas across Canada.

With CTS as a revenue booster, DIIG is expected to up its revenue to a $1.9 million range in 2009 and $4.5 million in 2010. By year-end 2014, the company is targeting $30 million in annualized revenues.

Diagnostic Imaging International Corp. was formerly known as Galloway Investments Corp. and changed its name to Diagnostic Imaging International Corp. It was incorporated in 2000 and is based in Las Vegas, Nevada.

In its recent chart, DIIG’s Bollinger Bands indicate greater than normal volatility as reflected by an increase in distance between the upper and lower bands. Trading within its Bollinger Bands, the stock reflects neither an overbought nor oversold condition relative to its recent price trend. With share prices currently above the stock’s 13-day moving average, a bullish signal is indicated, weakened by significant liquidating volume as reflected by downward sloping moving averages.

Human Genome Sciences Inc. (Nasdaq: HGSI) Stock Alert – HGSI Shares Surge on Positive Trial Results

Human Genome Sciences Inc. (HGS) (Nasdaq: HGSI) shares surged Monday, rallying more than 200%, as the company reported its lupus drug candidate BENLYSTA (belimumab, formerly LymphoStat-B) reduced the symptoms in a late stage clinical trial, compared to those who took a placebo. BENLYSTA reportedly blocks the activity of a naturally occurring protein required in the development of certain B cells, part of the immune system, that produce antibodies thought to play a key role in lupus and some other autoimmune diseases.

In a press release, David C. Stump M.D., executive vice president of Research and Development for HGS, stated, “BENLYSTA met the primary endpoint in this phase III study at a robust level of statistical significance. BENLYSTA also significantly reduced SLE disease activity versus placebo based on a number of other measures, including SELENA SLEDAI and Physician’s Global Assessment. Of note, a greater percentage of patients receiving BENLYSTA achieved a clinically meaningful reduction in steroid dose. We hope to have a full presentation of BLISS-52 results at an appropriate scientific meeting later in 2009.”

According to HGS, the drug would be the first new treatment for lupus to hit the market in about 50 years, with some analysts projecting the drug could eventually have sales topping $1 billion a year. The drug is being developed though a partnership with GlaxoSmithKline PLC of London.

Following the positive trial results, the companies expect to report a second major phase III clinical trial results in November, which could lead to a filing for U.S. and European regulatory approval during the first half of 2010, if results could also turn out positive.

Immediately following the news, Lazard upgraded HGSI from “Sell” to “Hold,” and Citigroup upped the equity from “Hold” to “Buy,” while bulls flock to options arena.

HGS is a commercially focused biopharmaceutical company. Aside from BENLYSTA, the company also has two other products in late-stage development: Albuferon for chronic hepatitis C and ABthraxtm for inhalation anthrax. Like BENLYSTA, Albuferon is also progressing toward commercialization.

In December 2008, the company reported that Albuferon met its primary endpoint in the first of two phase III clinical trials in chronic hepatitis C. HGS also has several drugs in earlier stages of clinical development for the treatment of cancer, led by its TRAIL receptor antibody HGS-ETR1 and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins.

In its recent chart, HGSI’s Bollinger Bands indicate greater than normal volatility as reflected by an increase in distance between the upper and lower bands. Trading above its upper Bollinger Band, the stock reflects an overextended condition relative to its recent price action and is due for either a pause or retracement. MACD reflects a strong bullish signal, with the indicator above the 9-day moving average signal line, and also above the 0 level, indicating that moving averages are trending higher. With share prices currently above the stock’s 13-day moving average, a bullish trend is indicated. Also, a rising moving average signals that there has been buying interest in this stock.

Halliburton Co. (NYSE: HAL) Stock Alert – HAL Tops Analysts Q2 Profit Forecast, but Warns on Further Weakening Industry

Halliburton Co. (NYSE: HAL), the world’s second-largest oil services company, recently announced higher-than-expected earnings for the second quarter of 2009 despite ongoing pressure from tumbling natural gas prices in the United States. Its stock rating has been cut at Gold Sachs last month amid persistent weakness in the North American natural gas market.

For the second quarter, Halliburton posted net profit of $262 million, or 29 cents per share, a decline from $504 million, or 55 cents per share, a year earlier.

On comparable basis, Halliburton posted earnings of 30 cents per share, excluding a $12 million charge to cut jobs, topping analysts’ average forecast of 26 cents, according to Reuters Estimates. Revenue dropped to $3.49 billion from $4.49 billion, while analysts had expected $3.41 billion.

However, the company warned that North American natural gas markets would stay weak throughout 2009. By the end of 2010, the company said margins in the international market, which it said tends to react more slowly to hydrocarbon pricing trends, would shrink by 3 to 5 percentage points.

“We believe it is unlikely that there will be a meaningful recovery in natural gas prices and, consequently, drilling activity for the remainder of the year,” CEO Dave Lesar stated in the press release.

“Weak global demand and volatility in the commodity markets continue to weigh on the oilfield services industry. The worldwide average rig count decreased 25% sequentially, further weakening industry fundamentals during the second quarter,” said the company said in a note.

Halliburton provides a variety of services and products to customers in the energy industry. The company operates under two divisions: the Completion and Production, and the Drilling and Evaluation segment.

The company offers a suite of services and products to customers through its two business segments for the exploration, development and production of oil and gas. In October 2008, the company acquired Pinnacle Technologies, Inc. (Pinnacle), a provider of microseismic fracture mapping services and tiltmeter mapping services. In July 2008, it acquired the remaining 49% interest in WellDynamics B.V. (WellDynamics) from Shell Technology Ventures Fund 1 B.V. (STV Fund). In June 2008, Halliburton acquired Protech Centerform, a provider of casing centralization services. In May 2008, it acquired Knowledge Systems Inc. (KSI), a provider of combined geopressure and geomechanical analysis software and services.

In its recent chart, HAL is trading within its Bollinger Bands, a normal condition signaling that the stock is neither overbought nor oversold relative to the recent price action. MACD reflects a weak bullish signal, with the indicator trending above the 9-day moving average signal line but still below the 0 level, indicating bearish moving averages. With share prices currently above the stock’s 13-day moving average, a bullish signal is indicated, weakened by significant liquidating volume as reflected by downward sloping moving averages.

Hasbro Inc. (NYSE: HAS) Stock Alert – HAS Sees Profit in Q2, Summer Movie Tie-in Toys Cited

Toy maker Hasbro Inc. (NYSE: HAS) reported an increase in profit for the second quarter, boosted by sales of toys tied to movies like Transformers and G.I. Joe.

“We couldn’t be more pleased with the performance both at the box office and at retail,” said CEO Brian Goldner in a release. “Retailers around the world recognize that certain brands like Transformers bring to life the entire store for consumers, which translates into premium placement and representation across multiple departments for those brands.”

Hasbro posted net revenues of $792.2 million, compared to $784.3 million a year ago, an increase of 1%. It said net revenues would have increased 7%, excluding the negative $44.5 million impact of foreign exchange. Net earnings came in at $39.3 million, or 26 cents per diluted share, compared to $37.5 million or 25 cents per diluted share in 2008.

The company said the 2009 second quarter results include a 6 cents per share dilutive impact from the its investment in its joint venture with Discovery Communications, inclusive of one-time deal expenses and financing costs associated with its recent issuance of long-term debt.

Analysts were looking for a profit of 23 cents per share on revenue of $797.1 million.

Going forward, the company said it will continue to invest in its business and closely manage its expenses.

“While there are challenges in 2009, we believe that the underlying strength of our brands and our commitment to our strategy should enable Hasbro to grow revenue and earnings per share, including the impact of our television investment — absent a material deterioration in the global economy and the value of foreign currencies,” Goldner said.

For next year, the toymaker said it will have movie tie-ins “Iron Man 2″ and “Toy Story 3.” On top of that, the company is developing movies with Universal based on Candyland, Monopoly and “Stretch Armstrong” line of board games .

Hasbro is engaged in providing children’s and family leisure time and entertainment products and services, including the design, manufacture and marketing of games and toys. Its offerings include a variety of games, including traditional board, card, hand-held electronic, trading card, role-playing and digital versatile disc (DVD) games, as well as electronic learning aids and puzzles.

Toy offerings include boys’ action figures, vehicles and playsets, girls’ toys, electronic toys, plush products, preschool toys and infant products, electronic interactive products, creative play and toy-related specialty products. Hasbro’s principal segments are United States (U.S.) and Canada and International. In March 2008, the company purchased all of the intellectual property rights related to the Trivial Pursuit brand from Horn Abbot Ltd. and Horn Abbot International Limited. In January 2008, the company acquired Cranium Inc.

In its recent chart, HAS’ MACD reflects a strong bullish signal, with the indicator above the 9-day moving average signal line, and also above the 0 level, indicating that moving averages are trending higher. With share prices currently above the stock’s 13-day moving average, a bullish trend is indicated. Also, a rising moving average signals that there has been buying interest in this stock. Trading near its upper Bollinger Band, the stock suggests high price relative to its recent price action.

Coca-Cola Company (NYSE: KO) Stock Alert – KO to Report Q2 Results on July 21

Atlanta-based Coca-Cola Company (NYSE: KO) is slated to announce its results for the fiscal second quarter on Tuesday before the opening bell.

Analysts expect the world’s biggest beverage maker to post second-quarter profit of 89 cents per share and revenue of $8.66 billion, according to a poll by Thomson Reuters. During last year’s second quarter, the company posted earnings of 96 cents per share.

According Michael Branca of Barclays Capital, he expects the total amount of product it sells around the world to grow 2.5% in the quarter, carried mostly by international growth.

Amid its struggle in North American sales, Coca-Cola is reaching overseas to expand into new areas. The company is reportedly buying a stake in British fruit and smoothie drinks maker Innocent Drinks.

In a note to clients, Brance said he expects a 2% unit case volume decline in North America, but said the currency trends are showing signs of improving and the company’s shares will grow as it benefits from global volume growth. He set a new price target earlier this month of $54.

The Coca-Cola Company is a manufacturer, distributor and marketer of nonalcoholic beverage concentrates and syrups in the world. Finished beverage products bearing its trademarks are sold in more than 200 countries. The company markets nonalcoholic sparkling brands, which include Diet Coke, Fanta and Sprite.

The company manufactures beverage concentrates and syrups, which it sells to bottling and canning operations, fountain wholesalers and some fountain retailers, as well as finished beverages, which it sells primarily to distributors. The company owns or licenses approximately 500 brands, including diet and light beverages, waters, enhanced waters, juices and juice drinks, teas, coffees and energy and sports drinks. During 2008, the company acquired the brands and licenses in Denmark and Finland from Carlsberg Group Beverages (Carlsberg).

In its recent chart, KO is trading within its Bollinger Bands, a normal condition signaling that the stock is neither overbought nor oversold relative to the recent price action. MACD reflects a strong bullish signal, with the indicator above the 9-day moving average signal line, and also above the 0 level, indicating that moving averages are trending higher. With share prices currently above the stock’s 13-day moving average, a bullish trend is indicated. Also, a rising moving average signals that there has been buying interest in this stock.

BeaconEquity.com Research Disclosure

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

BeaconEquity.com is a Web site wholly owned by BlueWave Advisors, LLC, which has been compensated twenty five thousand dollars as a marketing budget to manage a comprehensive investor awareness program including the creation and distribution of this report as well as other investor relations efforts. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.